Amplification of human MDM2 gene in human tumors

Details Amplification of human MDM2 gene in human tumors Amplification of human MDM2 gene in human tumors

2001-10-01

2008-07-22

Whiteman, Brian (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

Reexamination Certificate

active

07402570

ABSTRACT:
A human gene has been discovered which is genetically altered in human tumor cells. The genetic alteration is gene amplification and leads to a corresponding increase in gene products. Detecting that the gene, designated hMDM2, has become amplified or detecting increased expression of gene products is diagnostic of tumorigenesis. Human MDM2 protein binds to human p53 and allows the cell to escape from p53-regulated growth.

REFERENCES:
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 5004810 (1991-04-01), Draper
patent: 6184212 (2001-02-01), Miraglia et al.
patent: 6238921 (2001-05-01), Miraglia et al.
Opalinska et al. Nucleic acid therapeutics: Basic principles and recent applications. Nature Review, 2002, vol. 1, pp. 503-514.
Agrawal et al. Antisense therapeutics: is it as ismple as complementary base recognition? Molecular Medicine Today Feb. 2000, vol. 61, pp. 72-81.
Check, E. RNA to the rescue? Nature Sep. 2003, vol. 425, pp. 10-12.
Jen et al. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies. Stem Cells 2000, vol. 18, pp. 307-319.
Rojanaskul, Y. Antisense oligonucleotide therapeutics: drug delivery and targeting (1996) Ad. Drug. Deliv. Rev vol. 18, pp. 115-131.
James, W. Towards gene-inhibition therapy: a review of progess and prospects in the field of antiviral antisense nucleic acids and ribozymes. 1991 Antiviral Chemistry and Chemotherapy, vol. 2(4): pp. 191-214 (especially page.
Branch, A. A good antisense molecule is hard to find. Feb. 1998 TIBS, vol. 23: pp. 45-50.
Gerwitz et al. PNAS, 93:3161-3163, 1996.
Agrawal TIBTECH, 14 376-387, 1996.
Oliner, et al., “Amplification of a Gene Encoding a p53-Associated Protein in Human Sarcomas”,Nature, 358:80-83 (1992).
Culver et al.,TIG, 10(5), 1994, 174-178.
Marshall,Science, 269, 1995, 1050-1055.
Miller et al.,FASEB, 9, 1995, 190-199.
Rojanasakul,Ad. Drug. Del. Rev., 18 (1996), 115-131.
Burch & Mahan, “Oligonucleotides Antisense to the Interleukin 1 Receptor mRNA Block the Effects of Interleukin 1 in cultured Murine and Human Fibroblasts and in Mice,”J. Clin. Investigation, Inc. 88, 1190-96, Oct. 1991.
Dagle et al., “Physical properties of oligonucleotides containing phosphoramidate-modified internucleosides linkages,”Nucl. Acids Res. 19, 1805-10, 1991.
Flood et al., “Inhibition of Ly-6A Antigen Expression Prevents T Cell Activation,”J. Exp. Med. 172, 115-20, Jul. 1990.
Hambor et al., “Use of an Epstein-Barr virus Episomal Replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell clone,”Proc. Natl. Acad. Sci. USA 85, 4010-14, Jun. 1988; see p. 4011, col. 1, lines 40-45.
Harel-Bellan et al., “Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deox-oligonucleotide in human T lymphocytes,”J. Immunol. 140, 2431-35, Apr. 1988 (abstract).
Harel-Bellan et al., “Specific Inhibition of Lymphokine Biosynthesis and Autocrine Growth Using Antisense Oligonucleotides in Th 1 and Th2 Helper T Cell Clones,”J. Exp. Med. 168, 2309-18, Dec. 1988.
Morrison, “Suppression of Basic Fibroblast Growth Factor Expression by Antisense Oligodeoxynucleotides Inhibits the Growth of Transformed Human Astrocytes,”J. Biol. Chem. 266, 728-34, Jan. 15, 1991.
Sankar et al., Antisense oligonucleotide inhibition of encephalomyocarditis virus RNA translation,Eur. J. Biochem. 184, 39-45, Sep. 1989 (abstract).
Simons & Rosenberg, “Antisense nonmuscle myosin heavy chain and cmyb oligonucleotides suppress smooth muscle cell proliferation in vitro,”Cir. Res. 70, 835-43, Apr. 1992 (abstract).
Sumikawa & Miledi, “Repression of nicotinic acetylcholine receptor expression by antisense RNAs and an oligonucleotide,”Proc. Natl. Acad. Sci. USA 85, 1302-06, Feb. 1988.
Ulmann & Peyman, “Antisense Oligonucleotides: A New Therapeutic Principle,”Chemical Review 90, 544-84, Jun. 1990.
Watson et al., “Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer,”Cancer Res. 51, 3996-4000, Aug. 1991 (abstract).
Woolf et al., “The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides inXenopus oocytesand embryos,”Nucl. Acids Res. 18, 1763-69, 1990.
Zhang et al., “Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy,”Proc. Natl. Acad. Sci. USA 100, 11636-41, Sep. 30, 2003.
Bartel et al., “MDM2 and Its Splice Variant Messenger RNAs: Expression in Tumors and Down-Regulation Using Antisense Oligonucleotides,”Mol. Cancer Res. 2, 29-35, Jan. 2004.
Capoulade et al., “Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides,”Blood 97, 1043-49, Feb. 15, 2001.
Chen et al., “Synergistic activation of p53 by inhibition ofMDM2expression and DNA damage,”Proc. Natl. Acad. Sci. USA 95, 195-200, Jan. 1998.
Fiddler et al., “Amplification ofMDM2Inhibits MyoD-Mediated Myogenesis,”Mol. Cell. Biol. 16, 5048-57, Sep. 1996.
Goetz et al., “Requirement for Mdm2 in the Survival Effects of Bcr-Abl and Interleukin 3 in Hematopoietic Cells,”Cancer Res. 61, 7635-41, Oct. 15, 2001.
Sato et al., “Enhancement of Drug Induced Apoptosis by Antisense Oligodeoxynucleotides Targeted against Mdm2 and p21WAF1/CIPI,”Anticancer Research 20, 837-42, 2000.
Uhlmann & Peyman, “Antisense Oligonucleotides: A New Therapeutic Principle,”Chem Rev. 90, 543-84, 1990.
Wang et al., “MDM2 oncogene as a target for cancer therapy: An antisense approach,”Int. J. Oncol. 15, 653-60, 1999.
Wang et al., “Antisense Anticancer Oligonucleotide Therapeutics,”Current Cancer Drug Targets 1, 177-96, 2001.
Wang et al., “Chemosensitization and Radiosensitization of Human Cancer by Antisense Anti-MDM2 Oligonucleotides,”Ann. N.Y Acad. Sci. 1002, 217-35, 2003.
Zang & Wang, “Antisense Oligonucleotide Inhibitors of MDM2 Oncogene Expression,” inMethods in Molecular Medicine 85: Novel Anticancer Drug Protocols, pp. 205-222, Buolamwini & Adjei, eds., Humana Press, 2003.
Bjergård & Dahl, “Solid phase synthesis of oligodeoxyribonucleoside phosphorodithioates from thiophosphoroamidites,”Nucl. Acids Res. 19, 5843-50, 1991.
Hirashima et al., “Artificial Immune System against Viral Infection Involving antisense RNA Targeted to the 5′-Terminal Noncoding Region of Coliphage SP RNA,”J. Biochem. 106, 163-66 (1989).
Parker et al., “Targeted Gene Walking Polymerase Chain Reaction,”Nucl. Acids Res. 19. 3055-60, 1991.
Shuttleworth & Colman, “Antisense oligonucleotide-directed cleavage of mRNA inXenopusoocytes and eggs,”EMBO Journal 7, 427-34, 1988.
Stein & Cohen, “Oligodeoxynucleotides as Inhibitors of Gene Expression: A Review,”Cancer Res. 48, 2659-68, May 15, 1988.
Decision in Appeal No. 1997-3506 (U.S. Appl. No. 08/390,474), Jun. 30, 2001.
Fakharzadeh, et al., “Tumorigenic Potential Associated with Enhanced Expression of a Gene Tht is Amplified in a Mouse Tumor Cell Line”,The EMBO Journal,10(6):1565-1569 (1991).
Hinds, et al., “Mutant p53 DNA Clones From Human Colon Carcinomas Cooperate with Ras in Transforming Primary Rat Cells: A Comparison of the “Hot Spot” Mutant Phenotypes”,Cell Growth&Differentiation, 1:561-580 (1990).
Momand, et al., “The MDM2 Oncogene Product Forms a Complex with the p53 Protein and Inhibits p53-Mediated Transactivation,”Cell, 69:1237-1245 (1992).
Ladanyi, et al., “MDM2 Gene Amplification in Metastatic Osteosarcoma”,Cancer Research, 53:2231-2234 (1993).
Oliner, et al., “Oncoprotein MDM2 Conceals th

Affiliated with

Also associated with

Rating

Amplification of human MDM2 gene in human tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amplification of human MDM2 gene in human tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amplification of human MDM2 gene in human tumors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3971643